Zacks Research Has Strong Estimate for MD Q1 Earnings

Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) - Stock analysts at Zacks Research upped their Q1 2025 earnings per share (EPS) estimates for Pediatrix Medical Group in a note issued to investors on Thursday, March 6th. Zacks Research analyst Z. Masood now forecasts that the company will post earnings per share of $0.22 for the quarter, up from their previous forecast of $0.21. The consensus estimate for Pediatrix Medical Group's current full-year earnings is $1.38 per share. Zacks Research also issued estimates for Pediatrix Medical Group's Q2 2025 earnings at $0.38 EPS, Q3 2025 earnings at $0.38 EPS, Q4 2025 earnings at $0.41 EPS, Q1 2026 earnings at $0.25 EPS, Q2 2026 earnings at $0.39 EPS, Q3 2026 earnings at $0.36 EPS, Q4 2026 earnings at $0.42 EPS and FY2027 earnings at $1.25 EPS.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping analysts' consensus estimates of $0.37 by $0.12. The company had revenue of $502.36 million for the quarter, compared to the consensus estimate of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%.

MD has been the subject of a number of other reports. Truist Financial raised their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a "hold" rating in a report on Friday, February 21st. UBS Group lifted their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a "neutral" rating in a research note on Friday, February 21st. Macquarie started coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They set an "outperform" rating and a $18.00 price objective for the company. StockNews.com raised shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd. Finally, Mizuho upped their price target on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a "neutral" rating in a research report on Tuesday, November 19th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $17.08.

Remove Ads

Pediatrix Medical Group Price Performance

Shares of NYSE:MD traded down $0.34 during trading hours on Friday, hitting $14.01. 619,721 shares of the company's stock traded hands, compared to its average volume of 817,391. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. The company's fifty day simple moving average is $14.08 and its two-hundred day simple moving average is $13.33. Pediatrix Medical Group has a 52 week low of $6.62 and a 52 week high of $17.67. The company has a market cap of $1.20 billion, a price-to-earnings ratio of -11.67, a price-to-earnings-growth ratio of 1.74 and a beta of 1.49.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. Nomura Asset Management Co. Ltd. increased its stake in shares of Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after acquiring an additional 1,220 shares during the last quarter. Quest Partners LLC lifted its holdings in shares of Pediatrix Medical Group by 25.6% during the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company's stock valued at $35,000 after buying an additional 622 shares during the last quarter. Parkside Financial Bank & Trust grew its stake in shares of Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after buying an additional 1,040 shares in the last quarter. Quarry LP increased its holdings in Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company's stock worth $55,000 after buying an additional 1,662 shares during the last quarter. Finally, AlphaQuest LLC raised its position in Pediatrix Medical Group by 65.9% during the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after acquiring an additional 2,012 shares in the last quarter. Institutional investors and hedge funds own 97.71% of the company's stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.